Scientists have created a lifelike model of Amyotrophic Lateral Sclerosis (ALS), a type of motor neuron disease, using cells ...

After three long months, on Aug. 18, Nesbit's Lanes held a celebration marking its grand reopening. Now, a fundraiser for ...

This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope ...

A new landmark BCI study led by Stanford Medicine neuroscientists demonstrates a brain-computer interface capable of decoding ...

A compound normally associated with red blood cells may also play a game-changing antioxidant role in the brain, a study has ...

The influencer, 36, has partnered with adaptive clothing brand Silverts to launch a chic collection for young disabled people ...

The Gilded Age actress, 73, stepped out at the re-opening of Mamma Mia! at New York City's Winter Garden Theatre on Monday, ...

Clene Inc. plans to submit a New Drug Application (“NDA”) for lead candidate CNM-Au8® in ALS by year-end 2025. <li /> FDA meet ...

Ketamine product KETARx, produced by PharmaTher, has been approved by the FDA for use in surgical pain management.

New research has shown how hemoglobin acts as an antioxidant in brain cells, forming a target for neurodegenerative disease ...

During that second stay, a routine reflex test caused his leg to jerk violently, prompting a full spinal MRI. Shockingly, the ...

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...